Participation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort study.
Epidemiology
Juvenile idiopathic arthritis
Participation
Physical activity
Physical education
School
Journal
Pediatric rheumatology online journal
ISSN: 1546-0096
Titre abrégé: Pediatr Rheumatol Online J
Pays: England
ID NLM: 101248897
Informations de publication
Date de publication:
15 Jul 2019
15 Jul 2019
Historique:
received:
02
05
2019
accepted:
12
06
2019
entrez:
17
7
2019
pubmed:
17
7
2019
medline:
22
1
2020
Statut:
epublish
Résumé
The aim of the study was to describe school attendance and participation in physical education in school among children with juvenile idiopathic arthritis (JIA). Consecutive cases of JIA from defined geographical areas of Finland, Sweden and Norway with disease onset in 1997 to 2000 were followed for 8 years in a multi-center cohort study, aimed to be as close to population-based as possible. Clinical characteristics and information on school attendance and participation in physical education (PE) were registered. Participation in school and in PE was lowest initially and increased during the disease course. Eight years after disease onset 228/274 (83.2%) of the children reported no school absence due to JIA, while 16.8% reported absence during the last 2 months due to JIA. Full participation in PE was reported by 194/242 (80.2%), partly by 16.9%, and none by 2.9%. Lowest participation in PE was found among children with ERA and the undifferentiated categories. Absence in school and PE was associated with higher disease activity measures at the 8-year visit. School absence > 1 day at baseline predicted use of disease-modifying anti-rheumatic drugs, including biologics (DMARDs) (OR 1.2 (1.1-1.5)), and non-remission off medication (OR 1.4 (1.1-1.7) 8 years after disease onset. School absence at baseline predicted adverse long-term outcome. In children and adolescents with JIA participation in school activities is mostly high after 8 years of disease. For the minority with low participation, special attention is warranted to promote their full potential of social interaction and improve long-term outcome.
Sections du résumé
BACKGROUND
BACKGROUND
The aim of the study was to describe school attendance and participation in physical education in school among children with juvenile idiopathic arthritis (JIA).
METHODS
METHODS
Consecutive cases of JIA from defined geographical areas of Finland, Sweden and Norway with disease onset in 1997 to 2000 were followed for 8 years in a multi-center cohort study, aimed to be as close to population-based as possible. Clinical characteristics and information on school attendance and participation in physical education (PE) were registered.
RESULTS
RESULTS
Participation in school and in PE was lowest initially and increased during the disease course. Eight years after disease onset 228/274 (83.2%) of the children reported no school absence due to JIA, while 16.8% reported absence during the last 2 months due to JIA. Full participation in PE was reported by 194/242 (80.2%), partly by 16.9%, and none by 2.9%. Lowest participation in PE was found among children with ERA and the undifferentiated categories. Absence in school and PE was associated with higher disease activity measures at the 8-year visit. School absence > 1 day at baseline predicted use of disease-modifying anti-rheumatic drugs, including biologics (DMARDs) (OR 1.2 (1.1-1.5)), and non-remission off medication (OR 1.4 (1.1-1.7) 8 years after disease onset.
CONCLUSION
CONCLUSIONS
School absence at baseline predicted adverse long-term outcome. In children and adolescents with JIA participation in school activities is mostly high after 8 years of disease. For the minority with low participation, special attention is warranted to promote their full potential of social interaction and improve long-term outcome.
Identifiants
pubmed: 31307487
doi: 10.1186/s12969-019-0341-6
pii: 10.1186/s12969-019-0341-6
pmc: PMC6631827
doi:
Substances chimiques
Antirheumatic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
44Subventions
Organisme : Helse Nord RHF
ID : HNF 1450-19
Investigateurs
Gudmund Marhaug
(G)
Freddy Karup Pedersen
(FK)
Pekka Lahdenne
(P)
Boel Anderson-Gäre
(B)
Références
Clin Exp Rheumatol. 2001 Jul-Aug;19(4 Suppl 23):S1-9
pubmed: 11510308
J Rheumatol. 2001 Dec;28(12):2737-43
pubmed: 11764226
J Rheumatol. 2002 Sep;29(9):1989-99
pubmed: 12233897
J Rheumatol. 2003 Oct;30(10):2275-82
pubmed: 14528529
J Rheumatol. 2004 Nov;31(11):2290-4
pubmed: 15517647
Arthritis Rheum. 2005 Jul;52(7):2092-102
pubmed: 15986372
Arthritis Rheum. 2006 Nov;54(11):3573-82
pubmed: 17075863
Clin Psychol Rev. 2008 Mar;28(3):451-71
pubmed: 17720288
Arthritis Rheum. 2009 May 15;61(5):658-66
pubmed: 19405003
J Appl Physiol (1985). 2009 Oct;107(4):1006-14
pubmed: 19696361
Arthritis Care Res (Hoboken). 2010 Nov;62(11):1542-51
pubmed: 20597110
Arthritis Rheum. 2011 Sep;63(9):2809-18
pubmed: 21560116
BMC Pediatr. 2013 Jan 07;13:2
pubmed: 23289498
Diabetologia. 2013 Jun;56(6):1254-62
pubmed: 23435847
BMC Musculoskelet Disord. 2013 Mar 04;14:77
pubmed: 23497066
Pediatr Rheumatol Online J. 2013 Sep 14;11(1):33
pubmed: 24034206
PLoS One. 2014 Oct 20;9(10):e104642
pubmed: 25329390
Ann Rheum Dis. 2016 Jan;75(1):190-5
pubmed: 25362042
Semin Arthritis Rheum. 2015 Apr;44(5):542-550
pubmed: 25450240
Disabil Health J. 2015 Jul;8(3):317-24
pubmed: 25600476
Autoimmun Rev. 2015 Aug;14(8):726-34
pubmed: 25936296
Ann Rheum Dis. 2016 Jun;75(6):1092-8
pubmed: 25985972
J Rheumatol. 2015 Oct;42(10):1914-21
pubmed: 26329337
Pediatr Rheumatol Online J. 2015 Dec 10;13:57
pubmed: 26653716
Arthritis Care Res (Hoboken). 2017 Jul;69(7):1040-1049
pubmed: 27696793
Acta Paediatr. 2017 Jan;106(1):12-13
pubmed: 27943439
Br J Sports Med. 2017 Jul;51(14):1065-1072
pubmed: 28455366
Nat Rev Rheumatol. 2017 May 23;13(6):368-379
pubmed: 28533552
Arch Phys Med Rehabil. 2018 Jan;99(1):178-193.e1
pubmed: 28729171
Pediatr Rheumatol Online J. 2017 Aug 22;15(1):68
pubmed: 28830457
Scand J Rheumatol. 2018 Mar;47(2):117-121
pubmed: 28891743
Pediatr Allergy Immunol. 2018 Mar;29(2):174-179
pubmed: 29314343
Arthritis Res Ther. 2018 Jan 11;20(1):5
pubmed: 29325599
Arthritis Care Res (Hoboken). 2018 Nov;70(11):1661-1670
pubmed: 29409123
Scand J Rheumatol. 2019 Mar;48(2):105-113
pubmed: 30270708
Pediatr Rheumatol Online J. 2018 Oct 17;16(1):64
pubmed: 30333025
Pediatr Rheumatol Online J. 2018 Oct 22;16(1):67
pubmed: 30348221
Arthritis Care Res (Hoboken). 2019 Feb;71(2):271-280
pubmed: 30354015
Pediatr Rheumatol Online J. 2019 Feb 11;17(1):6
pubmed: 30744659
Arthritis Care Res (Hoboken). 2019 Feb 14;:null
pubmed: 30762291
Arthritis Rheum. 1994 Dec;37(12):1761-9
pubmed: 7986222
Br J Rheumatol. 1997 Nov;36(11):1218-23
pubmed: 9402869